Botulinum toxin A in the hemiplegic upper limb: A double blind trial

Developmental Medicine and Child Neurology

Volumn 39, Issue 3, 1997, Pages 185-193

  Corry, I S ^a   Cosgrove, A P ^a   Walsh, E G ^a   McClean, D ^a   Graham, H K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; EMLA; SODIUM CHLORIDE;

ADOLESCENT; ARM; ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ELBOW FLEXION; FEMALE; FLEXOR MUSCLE; HAND FUNCTION; HAND GRIP; HEMIPLEGIA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; MUSCLE TONE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; THUMB; WRIST;

EID: 0030991019     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.1997.tb07408.x     Document Type: Article

References (19)

1. Ashworth B. (1964) Preliminary trial of carisoprodol in multiple selerosis. Journal of the American Medical Association 192:540-2.
2. Bleck EE. (1987) Orthopaedic Management in Cerebral Palsy, Clinics in Developmental Medicine No. 99-100. London: Mat-Keith Press. Chapter 7.
3. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. (1990) Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head & Shoulder 12:392-8.
4. Burgen ASV, Dickens E, Zatman LJ. (1949) The action of botulinum toxin on the neuro-muscular junction. Journal of Physiology 109:10-24.
5. Cosgrove AP, Graham HK. (1994) Botulinum A prevents the development of contractures in the hereditary spastic mouse. Developmental Medicine and Child Neurology 36:379-85.
6. _ Corry IS, Graham HK. (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medicine and Child Neurology 36:386-96.
7. Das TK, Park DM. (1989) Botulinum toxin in treating spasticity. British Journal of Clinical Practice 43:401-3.
8. Duchen LW, Strich S. (1968) The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Quarterly Journal of Experimental Physiology 53:84-9.
9. Goldspink G, Tabary C, Tabary JC, Tardieu C, Tardieu G. (1974) Effect of denervation on the adaptation of sarcomere number and muscle extensibility to the functional length of the muscle. Journal of Physiolog,y 236:733-42.
10. Holly RG Barnett JG, Ashmore RG, Mole PA. (1980) Stretch induced growth in chicken wing muscles: a new model of stretch hypertrophy. American Journal of Physiology 238:C62-71.
11. House JH, Gwathney FW, Fidler MO. (1981) A dynamic approach to the thumb-in-palm deformity in cerebral palsy. Journal of Bone and Joint Surgery 63A: 216-25.
12. Huet de la Tour E, Tardieu C, Tabary JC, Tabary C. (1979) Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following a local injection of tetanus toxin. Journal of Neurological Science 40:123-31.
13. Reddihough D, Bach T, Burgess G, Oke L, Hudson I. (1991) Comparison of subjective and objective measures of movement performance of children with cerebral palsy. Developmental Medicine and Child Neurology 33:578-84.
14. Sanders DBDB, Massey EW, Buckley EG. (1986) Botulinum toxin for blepharospasm: single-fibre EMG studies. Nurology 36:545-7.
15. Tonkin MA. (1995) The upper limb in cerebral palsy. Current Orthopaedics 9:149-55.
16. Tsui JK, Snow BJ, Calne DB. (1992) Treatment of spasticity with botulinum toxin. Annals of Neurology 31:113. (Letter).
17. Wall SA, Chait LA, Temlett JA, Perkins B, Hilien G, Becker P (1993) Botulinum A chemodenervation: a new modality in cerebral palsied hands. British Journal of Hnxtir Surgery 46:703-6.
18. Walsh EG. (1988) Assessment of human hemiplegic spasticity by a resonant frequency method. Clinical Biomechancs 3:173-8.
19. _ (1992) Muscles Masses and Motion: The Physiology of Normality, Hypotonicity Spasticity and Rigidity. Clinics in Developmental Medicine No. 125, London:MacKeith Press.